Current Report · Items 2.02, 9.01 · 8-K
NRX Pharmaceuticals, Inc.
NRXPNASDAQEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 17, 2026, NRx Pharmaceuticals, Inc. (the “Company”) announced via press release its results for the second quarter ended June 30, 2026. A copy of the Company’s press release is hereby furnished and incorporated herein by reference as Exhibit 99.1. Item 9.01. Financial Statements and Exhibits. Exhibit Description No.…
Company context
Current securities
Historical securities (7)
BRPANASDAQ · EQUITY · Historical · closed Nov 15, 2020BRPANSDQ · EQUITY · Historical · closed May 25, 2021BRPARNASDAQ · RIGHT · Historical · closed May 25, 2021BRPAUNASDAQ · UNIT · Historical · closed May 25, 2021BRPAUNASDAQ · UNIT · Historical · closed Dec 14, 2020BRPAWNASDAQ · WARRANT · Historical · closed May 25, 2021NRXPWNASDAQ · WARRANT · Historical · closed May 22, 2026
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02 Results of Operations and Financial Condition.
On August 17, 2026, NRx Pharmaceuticals, Inc. (the “Company”) announced via press release its results for the second quarter ended June 30, 2026. A copy of the Company’s press release is hereby furnished and incorporated herein by reference as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
Exhibit Description
No.
──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
99.1 Press Release dated August 17, 2026.
104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.